Breakthrough Capital
VC Fund
Nanjing, China
Breakthrough Capital is a venture capital partner that focuses on the transformation and investment of emerging technologies.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Breakthrough Capital invests in
Stages Breakthrough Capital invests in
Countries Breakthrough Capital invests in
Investment Focus
Industry
- Medical 2 (33%)
- Health Care 2 (33%)
- Biotechnology 2 (33%)
- Manufacturing 2 (33%)
- Genetics 1 (17%)
Stage
- Series A 2 (33%)
- Venture - Series Unknown 2 (33%)
- Seed 1 (17%)
- Series C 1 (17%)
Country
- China 5 (83%)
- Colombia 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sino-Biocan
|
Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization. | $15.7M / Series A / Mar 15, 2022 | |
REALY
|
REALY is a medical equipment and device manufacturing company. | Venture - Series Unknown / Jan 01, 2022 | |
Belle Healthcare
|
Belle Healthcare provides surgery equipments for hospitals. Their products include lenticule removal forceps, stainless steel belle scissors, capsulotomy scissors, iris scissors, and Vannas capsulotomy scissors. | Venture - Series Unknown / Jan 01, 2022 | |
Yuce Biological Technology
|
Shenzhen Yuce Biotechnology Co., Ltd. focuses on genetic testing services for tumor precision immunotherapy, with "gene" + "immunity" as its wings, organically combining tumor genome and immune microenvironment. | $14.1M / Series C / Nov 11, 2021 | |
MetWare
|
Maiwei Metabolism is a developer of novel medical metabolic technology, specializing in the use of cutting-edge metabolomics technology in the domains of life science research and medicine. | $15.5M / Series A / Sep 24, 2021 | |
Qinaya
|
Qinaya offers a range of web design and development, SEO, print advertising, and corporate graphic line services. | $200K / Seed / Feb 23, 2021 |
Co-Investors
HSG
1 deal together
Innovation Works
1 deal together
LINK Capital
1 deal together
Rivercity Investment
1 deal together
HSG
1 deal together
Tzitzit Aseet
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Breakthrough Capital invest in?
Breakthrough Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Venture - Series Unknown stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Breakthrough Capital last invest?
The most recent investment recorded for Breakthrough Capital closed in Mar 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
